Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04230447 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)

Study acronym: SAE
StatusRecruiting
PhaseNot specified
SponsorYi Li, MD
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Jan 1, 2030 to Nov 1, 2026
    • Start date changed from estimate of Jan 14, 2020 to Feb 1, 2021
    • Study sites: 0 to 1
    • Study description shortened, about 3 words
    • Study title expanded, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, the researcher involved the sepsis patients(defined by sepsis 3.0) in Peking Union Medical College Hospital. The SAE was defined as the Glasgow Coma Scale (GCS) score of less than 15 and the Non-SAE group GCS = 15. The control group was the non-infectious patients with acute disease strikes and the healthy control. After the sample collection, the RNA-sequence, metabolites and cytokines were under detection.
Trial Details
NCT Number NCT04230447
Lead Sponsor Yi Li, MD
Conditions
(from sponsor)		 Sepsis-Associated Encephalopathy
Related terms Sepsis-Associated Encephalopathy
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov